These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 22085136

  • 1. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D, Andersen MD, Gede LB, de Franca TK, Jørgensen SR, Schwarz P, Jørgensen NR.
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM.
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [Abstract] [Full Text] [Related]

  • 4. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T.
    Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
    [Abstract] [Full Text] [Related]

  • 5. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D.
    Arch Biochem Biophys; 2008 May 15; 473(2):218-24. PubMed ID: 18358824
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone - a bone anabolic and catabolic agent.
    Poole KE, Reeve J.
    Curr Opin Pharmacol; 2005 Dec 15; 5(6):612-7. PubMed ID: 16181808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC, Poulton IJ, McGregor NE, Ho PW, Allan EH, Quach JM, Martin TJ, Sims NA.
    J Bone Miner Res; 2012 Apr 15; 27(4):902-12. PubMed ID: 22190112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH.
    Bull Math Biol; 2000 Jan 15; 62(1):163-88. PubMed ID: 10824426
    [Abstract] [Full Text] [Related]

  • 12. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
    Koh AJ, Demiralp B, Neiva KG, Hooten J, Nohutcu RM, Shim H, Datta NS, Taichman RS, McCauley LK.
    Endocrinology; 2005 Nov 15; 146(11):4584-96. PubMed ID: 16081645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.
    Siddiqui JA, Le Henaff C, Johnson J, He Z, Rifkin DB, Partridge NC.
    Bone; 2021 Feb 15; 143():115762. PubMed ID: 33212319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone: a double-edged sword for bone metabolism.
    Qin L, Raggatt LJ, Partridge NC.
    Trends Endocrinol Metab; 2004 Mar 15; 15(2):60-5. PubMed ID: 15036251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.